An Indian government investigation has found that duty-free shops at Mumbai’s Chhatrapati Shivaji Maharaj International Airport, operated by the Adani Group, violated regulations by selling nicotine pouches that authorities classify as a public health concern. The findings, outlined in official investigation documents, have triggered a legal dispute over the sale of nicotine products at airport duty-free outlets.
The Adani Group has denied any wrongdoing and has challenged the findings in court. According to court documents, the company argues that the provisions of India’s Drugs and Cosmetics Act do not apply to duty-free shops or to nicotine pouches sold within such outlets. The matter is now awaiting judicial review.
Legal experts say the case could establish an important precedent for the regulation of nicotine products sold at duty-free stores across India. If the government’s position is upheld, airport retailers may be prohibited from selling nicotine pouches, one of the fastest-growing nicotine products in global markets.
The outcome of the case is expected to have significant implications for airport retail operations, public health policy, and the regulation of emerging nicotine products in India. Authorities and industry stakeholders are closely monitoring the proceedings, as the court’s decision could shape future enforcement and compliance standards for duty-free businesses nationwide.
